Wettswil a.A., Switzerland

Maya Gulotti-Georgieva



 

Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Maya Gulotti-Georgieva

Introduction

Maya Gulotti-Georgieva, located in Wettswil a.A., Switzerland, is an accomplished inventor with a notable contribution to the field of biotechnology. With five patents to her name, she has pushed the boundaries of science, particularly in the area of recombinant binding proteins. Her work has potential applications in the treatment of various diseases, demonstrating the profound impact of her innovations.

Latest Patents

Maya’s latest patents involve cutting-edge research on recombinant binding proteins. These inventions include new designed ankyrin repeat domains that possess binding specificity for serum albumin, hepatocyte growth factor (HGF), and vascular endothelial growth factor (VEGF-A). Her patents also cover nucleic acids encoding these designed ankyrin repeat domains, pharmaceutical compositions that incorporate them, and their applications in disease treatment. The depth of her research is evidenced by the complexity and specificity of the proteins and domains she has developed.

Career Highlights

Maya currently works at Molecular Partners AG, a company that excels in the field of biopharmaceuticals. Her role there has been pivotal in advancing new therapies that leverage her unique innovations. Over the years, her dedication to research and development has contributed significantly to the company's achievements in creating impactful therapeutic solutions.

Collaborations

Throughout her career, Maya has collaborated with notable professionals in her field, including Hans Kaspar Binz and Douglas Phillips. These partnerships have allowed her to enhance her research capabilities and expand the applicability of her innovations, facilitating the translation of scientific discoveries into real-world health solutions.

Conclusion

Maya Gulotti-Georgieva exemplifies the role of inventors in today’s scientific landscape. Her contributions to the development of recombinant binding proteins not only highlight her innovative spirit but also signify her dedication to improving health outcomes. As she continues her work at Molecular Partners AG, the impact of her inventions will undoubtedly resonate within the biotechnology sector and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…